Literature DB >> 26044356

Natural products as inhibitors of recombinant cathepsin L of Leishmania mexicana.

Lorena R F de Sousa1, Hongmei Wu2, Liliane Nebo3, João B Fernandes3, Maria F das G F da Silva3, Werner Kiefer2, Tanja Schirmeister2, Paulo C Vieira4.   

Abstract

Cysteine proteinases (cathepsins) from Leishmania spp. are promising molecular targets against leishmaniasis. Leishmania mexicana cathepsin L is essential in the parasite life cycle and a pivotal in virulence factor in mammals. Natural products that have been shown to display antileishmanial activity were screened as part of our ongoing efforts to design inhibitors against the L. mexicana cathepsin L-like rCPB2.8. Among them, agathisflavone (1), tetrahydrorobustaflavone (2), 3-oxo-urs-12-en-28-oic acid (3), and quercetin (4) showed significant inhibitory activity on rCPB2.8 with IC50 values ranging from 0.43 to 18.03 µM. The mechanisms of inhibition for compounds 1-3, which showed Ki values in the low micromolar range (Ki = 0.14-1.26 µM), were determined. The biflavone 1 and the triterpene 3 are partially noncompetitive inhibitors, whereas biflavanone 2 is an uncompetitive inhibitor. The mechanism of action established for these leishmanicidal natural products provides a new outlook in the search for drugs against Leishmania.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biflavonoid; Cathepsin L; Leishmania mexicana; Triterpene; rCPB2.8

Mesh:

Substances:

Year:  2015        PMID: 26044356     DOI: 10.1016/j.exppara.2015.05.016

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

Review 1.  Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine.

Authors:  Dengyu Yang; Tiancheng Wang; Miao Long; Peng Li
Journal:  Oxid Med Cell Longev       Date:  2020-12-30       Impact factor: 6.543

2.  Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures.

Authors:  Maria Cecilia Fernandes; Laura A L Dillon; Ashton Trey Belew; Hector Corrada Bravo; David M Mosser; Najib M El-Sayed
Journal:  mBio       Date:  2016-05-10       Impact factor: 7.867

3.  Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health.

Authors:  Bahare Salehi; Laura Machin; Lianet Monzote; Javad Sharifi-Rad; Shahira M Ezzat; Mohamed A Salem; Rana M Merghany; Nihal M El Mahdy; Ceyda Sibel Kılıç; Oksana Sytar; Mehdi Sharifi-Rad; Farukh Sharopov; Natália Martins; Miquel Martorell; William C Cho
Journal:  ACS Omega       Date:  2020-05-14

Review 4.  Natural Products That Target the Arginase in Leishmania Parasites Hold Therapeutic Promise.

Authors:  Nicola S Carter; Brendan D Stamper; Fawzy Elbarbry; Vince Nguyen; Samuel Lopez; Yumena Kawasaki; Reyhaneh Poormohamadian; Sigrid C Roberts
Journal:  Microorganisms       Date:  2021-01-28

5.  Novel Synthesized N-Ethyl-Piperazinyl-Amides of C2-Substituted Oleanonic and Ursonic Acids Exhibit Cytotoxic Effects through Apoptotic Cell Death Regulation.

Authors:  Oxana Kazakova; Alexandra Mioc; Irina Smirnova; Irina Baikova; Adrian Voicu; Lavinia Vlaia; Ioana Macașoi; Marius Mioc; George Drăghici; Ştefana Avram; Cristina Dehelean; Codruța Şoica
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

6.  Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach.

Authors:  Florencia Ferraro; Alicia Merlino; Nicolás Dell Oca; Jorge Gil; José F Tort; Mercedes Gonzalez; Hugo Cerecetto; Mauricio Cabrera; Ileana Corvo
Journal:  PLoS Negl Trop Dis       Date:  2016-07-27

Review 7.  Therapeutic Potential of Ursonic Acid: Comparison with Ursolic Acid.

Authors:  Juhyeon Son; Sang Yeol Lee
Journal:  Biomolecules       Date:  2020-11-02

8.  Design, synthesis and biological evaluation of N-oxide derivatives with potent in vivo antileishmanial activity.

Authors:  Leandro da Costa Clementino; Guilherme Felipe Santos Fernandes; Igor Muccilo Prokopczyk; Wilquer Castro Laurindo; Danyelle Toyama; Bruno Pereira Motta; Amanda Martins Baviera; Flávio Henrique-Silva; Jean Leandro Dos Santos; Marcia A S Graminha
Journal:  PLoS One       Date:  2021-11-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.